智通财经APP获悉，3月16日，医渡科技(02158)持续加码股份回购，当日耗资超1100万港元，延续连日来高密度、大手笔的回购节奏，以坚定的资本动作，再度彰显管理层对公司内在价值的高度认可，以及对AI医疗赛道长期发展的充足信心。
截至目前，公司2026年以来回购动作连贯且亮眼，年内累计回购次数稳步攀升，累计耗资超过2.1亿港元，库存股占比近4.5%，持续刷新公司历史峰值，成为继友邦保险等长期巨头后，极少数触及这一“顶级阈值”的企业，回购强度领跑港股中小市值企业，市场认可度持续凸显。
强劲回购的底气，源于公司扎实的业务落地与创新突破。近期，医渡科技重磅发布医渡智循临床循证智能体，精准赋能临床诊疗与医学科研，补齐临床AI循证决策短板；同时积极走进海南博鳌乐城国际医疗旅游先行区，深化医疗AI务实合作，助力真实世界研究落地与基层医疗提质，实现“资本端稳预期、业务端强增长”的双轮驱动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.